Published February 21, 1984 | Version v1
Patent

Radioimmunoassay for cyclic nucleotides

Creators

Description

An improved radioimmunoassay for the determination of cyclic nucleotides in body fluids which comprises adding a source of divalent cation prior to assay minimizes the effects of both endogenous calcium ion and EDTA used as an anticoagulant in blood plasma samples

Availability note (English)

U.S. Commissioner of Patents, Washington, D.C. 20231, USA, $.50.

Additional details

Publishing Information

Imprint Pagination
v p.
IPC:
Int. Cl. G01N 33/56; G01N 33/58; G01N 33/60.
IPC
Int. Cl. G01N 33/56; G01N 33/58; G01N 33/60.
Patent number
US patent document 4,433,061/A/

INIS

Country of Publication
United States
Country of Input or Organization
United States
INIS RN
16014184
Subject category
S62: RADIOLOGY AND NUCLEAR MEDICINE;
Resource subtype / Literary indicator
Non-conventional Literature
Descriptors DEI
ADDITIVES; ANTICOAGULANTS; BLOOD COAGULATION; BLOOD PLASMA; BODY FLUIDS; CALCIUM IONS; CATIONS; CHEMICAL COMPOSITION; EDTA; NUCLEOTIDES; RADIOIMMUNOASSAY
Descriptors DEC
AMINO ACIDS; ATOMIC IONS; BIOLOGICAL MATERIALS; BLOOD; CARBOXYLIC ACIDS; CHARGED PARTICLES; CHELATING AGENTS; DRUGS; HEMATOLOGIC AGENTS; IONS; ISOTOPE APPLICATIONS; MATERIALS; ORGANIC ACIDS; ORGANIC COMPOUNDS; TRACER TECHNIQUES

Optional Information

Notes
PAT-APPL-269155.